{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:00:54Z","timestamp":1791824454032,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["2017-2022"],"award-info":[{"award-number":["2017-2022"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1994\/A28701"],"award-info":[{"award-number":["C1994\/A28701"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1094\/A25616"],"award-info":[{"award-number":["C1094\/A25616"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C2422\/A2564"],"award-info":[{"award-number":["C2422\/A2564"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["2019-2024"],"award-info":[{"award-number":["2019-2024"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017008","name":"Cancer Research UK Manchester Centre","doi-asserted-by":"publisher","award":["C147\/A25254"],"award-info":[{"award-number":["C147\/A25254"]}],"id":[{"id":"10.13039\/501100017008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["NIHR129943"],"award-info":[{"award-number":["NIHR129943"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0801525\/1"],"award-info":[{"award-number":["G0801525\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_18056"],"award-info":[{"award-number":["MC_PC_18056"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ebiom.2024.105032","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T18:32:15Z","timestamp":1708540335000},"page":"105032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial"],"prefix":"10.1016","volume":"101","author":[{"given":"Tim A.D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-3449","authenticated-orcid":false,"given":"Catharine M.L.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuradh","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joely","family":"Irlam-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley J.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Pei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5187-7038","authenticated-orcid":false,"given":"Mark","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed A.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Denley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Huddart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5.5","key":"10.1016\/j.ebiom.2024.105032_bib1","article-title":"NCCN guidelines updates: management of muscle-invasive bladder cancer","volume":"17","author":"Flaig","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105032_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.ebiom.2024.105032_bib3","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105032_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105032_bib5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/bjc.1997.531","article-title":"The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix","volume":"76","author":"West","year":"1997","journal-title":"Br J Cancer"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105032_bib6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"33","key":"10.1016\/j.ebiom.2024.105032_bib7","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105032_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105032_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ijrobp.2021.03.001","article-title":"Long-term outcomes of radical radiation therapy with hypoxia modification with biomarker discovery for stratification: 10-year update of the BCON (bladder carbogen nicotinamide) phase 3 randomized trial (ISRCTN45938399)","volume":"110","author":"Song","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105032_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105032_bib11","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-17-0038","article-title":"A\u00a0gene signature for selecting benefit from hypoxia modification of radiotherapy for high-risk bladder cancer patients","volume":"23","author":"Yang","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105032_bib12","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1158\/1078-0432.CCR-12-0891","article-title":"Validation of a radiosensitivity molecular signature in breast cancer","volume":"18","author":"Eschrich","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2024.105032_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.urolonc.2020.08.023","article-title":"The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: a systematic review and meta-analysis","volume":"39I","author":"Parizi","year":"2021","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105032_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A\u00a0consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105032_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ijrobp.2009.05.056","article-title":"Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105032_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12874-019-0666-3","article-title":"A\u00a0review of spline function procedures in R","volume":"6","author":"Perperoglou","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105032_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/sim.4780080803","article-title":"A\u00a0linear regression model for the analysis of life times","volume":"8","author":"Aalen","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2024.105032_bib18","first-page":"352","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"27","author":"Greenland","year":"2016","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105032_bib19","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/aps.2017.79","article-title":"Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells","volume":"38","author":"Li","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105032_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.oraloncology.2008.04.002","article-title":"Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest","volume":"45","author":"Yoshiba","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ebiom.2024.105032_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2407-13-331","article-title":"Effects of hypoxia on human cancer cell line chemosensitivity","volume":"13","author":"Strese","year":"2013","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105032_bib22","first-page":"4154","article-title":"Activity of mitomycin C for aerobic and hypoxic cells in\u00a0vitro and in\u00a0vivo","volume":"43","author":"Rauth","year":"1983","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105032_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A\u00a0gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105032_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A\u00a0genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105032_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2019.01.011","article-title":"Impact of immune and stromal infiltration on outcomes following bladder-sparing trimodality therapy for muscle-invasive bladder cancer","volume":"76","author":"Efstathiou","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ebiom.2024.105032_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ebiom.2024.105032_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.ebiom.2024.105032_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0167-8140(91)90033-D","article-title":"Dose fractionation and tumour repopulation in radiotherapy for bladder cancer","volume":"21","author":"Maciejewski","year":"1991","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105032_bib29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ijrobp.2010.10.007","article-title":"Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia","volume":"79","author":"Carlson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105032_bib30","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac047e","article-title":"Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes","volume":"66","author":"Chvetsov","year":"2021","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105032_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijrobp.2005.02.038","article-title":"Early reoxygenation in tumors after irradiation: de termining factors and consequences for radiotherapy regimens using daily multiple fractions","volume":"63","author":"Crokart","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105032_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2008.10.015","article-title":"Repeated tumor pO(2) measurements by multi-site EPR\u00a0oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy","volume":"91","author":"Hou","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ebiom.2024.105032_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmed.2019.00117","article-title":"Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma","volume":"6","author":"G\u00e9rard","year":"2019","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105032_bib34","first-page":"76","article-title":"Cycling hypoxia: a key feature of the tumor microenvironment","volume":"1866","author":"Michiels","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105032_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s13246-022-01173-9","article-title":"Analysis of tumour dose-response data from animal experiments via two TCP models accounting for tumor hypoxia and resensitization","volume":"45","author":"Stavrev","year":"2022","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.ebiom.2024.105032_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","article-title":"Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK\/01\/004)","volume":"87","author":"Huddart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1112","key":"10.1016\/j.ebiom.2024.105032_bib37","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190250","article-title":"Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia","volume":"93","author":"Joseph","year":"2020","journal-title":"Br J Radiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:36:24Z","timestamp":1778873784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S2352396424000677"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105032","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105032"}}